# Acute Control of Chronic Hypertension

> **NCT03877692** · PHASE4 · TERMINATED · sponsor: **Albany Medical College** · enrollment: 10 (actual)

## Conditions studied

- Preeclampsia With Severe Features
- Chronic Hypertension in Obstetric Context

## Interventions

- **DRUG:** Experimental dosing of labetalol
- **OTHER:** Standard dosing of labetalol

## Key facts

- **NCT ID:** NCT03877692
- **Lead sponsor:** Albany Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-18
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-07-20
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877692, "Acute Control of Chronic Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03877692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*